| Typicality: | 0.266 |
| Saliency: | 0.242 |
| on anyone anywhere in the world | 12 | transitive-object |
| on the clinical trials | 4 | location |
| on the competition | 3 | location |
| act → have → adverse impact | 5 |
| act → have → adverse effect | 4 |
| act → have → material adverse effect | 4 |
| act → have → significant adverse effect | 3 |
| negative | neutral | positive |
| 0.593 | 0.393 | 0.015 |
| Raw frequency | 16 |
| Normalized frequency | 0.242 |
| Modifier score | 0.500 |
| Perplexity | 265.815 |